Quaker Chemical Corporation Announces Third Quarter 2012 Results

- Acquisitions and business strategies drive Company to record product volumes

- Revenue down slightly due to foreign exchange impacts

- Strong balance sheet and net operating cash flow

- Solid earnings despite challenging environment

Oct 30, 2012, 16:05 ET from Quaker Chemical Corporation

CONSHOHOCKEN, Pa., Oct. 30, 2012 /PRNewswire/ -- Quaker Chemical Corporation (NYSE: KWR) today announced net sales of $180.9 million for the third quarter of 2012, compared to third quarter 2011 net sales of $182.3 million.  Earnings per diluted share were $0.80 for the third quarter of 2012, compared to earnings per diluted share of $1.03 for the third quarter of 2011 or $0.81 excluding a non-cash gain on the revaluation of a previously held ownership interest in a Mexican affiliate of $0.22 per diluted share.  The third quarter of 2012 includes certain uncommon expenses totaling $0.05 per diluted share largely consisting of severance and Brand launch costs.  In addition, changes in foreign exchange rates negatively impacted the third quarter net sales by $10.6 million, or 6%, and net income by $0.04 per diluted share. 

(Logo: http://photos.prnewswire.com/prnh/20120910/PH70044LOGO )

Michael F. Barry, Chairman, Chief Executive Officer and President, commented, "We are very pleased to announce record product volumes, solid earnings and strong cash flow again this quarter.  The global markets remain challenging for us and we are being negatively impacted by a stronger dollar and weaker demand in several geographical areas such as Europe, China, Brazil and India.  Despite these headwinds, we delivered record product volumes this quarter by continuing to grow through additional new business and our recent acquisitions." 

Mr. Barry continued, "As we look to the fourth quarter, we expect the challenging global economic environment to continue as well as some negative seasonality impacts around the holidays at year end.  However, we remain committed to delivering good results through the execution of our business strategies.  Overall, our expectations and guidance have not changed for our full year results and we expect 2012 to be another good year for Quaker." 

Mr. Barry also noted, "With our strong balance sheet, we are able to continue actively pursuing acquisitions consistent with our third quarter acquisition of NP Coil Dexter, closed in July.  This is the fifth acquisition we have made during the past two years as we continue to add new adjacent product lines which we can leverage on our global platform.  In addition, we launched a revised Brand for Quaker.  Building on our 94-year history, we are committed to take the Company to the next level.  Our revitalized Brand highlights this commitment by more clearly communicating our competitive advantage: formulating products and service solutions for our customers through the innovation, expertise and experience of our people."  

Third Quarter 2012 Summary

Net sales for the third quarter of 2012 were $180.9 million, a decrease of less than 1% from $182.3 million in the third quarter of 2011.  Foreign exchange rate translation decreased revenues by approximately 6%, which more than offset increases due to product volumes of approximately 5%, including acquisitions.  

Gross profit decreased by approximately $0.4 million, or less than 1%, from the third quarter of 2011.  The third quarter of 2012 gross margin increased slightly to 32.7% from 32.6% for the third quarter of 2011.  The decrease in gross profit is consistent with the decrease in net sales noted above.  

Selling, general and administrative expenses ("SG&A") increased approximately $1.3 million compared to the third quarter of 2011, primarily related to acquisitions and higher selling, inflationary and other labor related costs which were partially offset by decreases due to foreign exchange rate translation.  SG&A for the third quarter of 2012 includes certain uncommon charges totaling $0.05 per diluted share largely consisting of severance and related items and costs related to the Company's new Brand launch.  As a result, the third quarter of 2012 SG&A, as a percentage of sales, increased to 23.9% compared to 23.0% for the third quarter of 2011. 

The decrease in interest expense was due to lower average borrowings, partially offset by increases related to the accretion of certain acquisition-related liabilities. 

The decrease in other income in the third quarter of 2012 was primarily due to a $2.7 million, or $0.22 per diluted share, non-cash gain recorded in the third quarter of 2011 due to the revaluation of the Company's previously held ownership interest in its Mexican equity affiliate to its fair value, which was related to the Company's third quarter of 2011 purchase of the remaining ownership interest in this entity. 

Year-to-Date Summary

Net sales for the first nine months of 2012 were $535.4 million, an increase of 5% from $510.0 million for the first nine months of 2011.  Product volumes, including acquisitions, were higher by approximately 6%, and selling price and mix increased revenues by 4%, while foreign exchange rate translation decreased revenues by approximately 5%. 

Gross profit increased by approximately $13.6 million, or 8%, from the first nine months of 2011, with gross margin increasing to 33.5% from 32.5%, for the first nine months of 2011, reflecting the Company's initiative to restore margins to more acceptable levels through price increases and the mix effects noted above.  

SG&A increased by approximately $10.6 million compared to the first nine months of 2011, primarily related to acquisitions and higher selling, inflationary and other costs on increased business activity, which were partially offset by decreases due to foreign exchange rate translation.  The first nine months of 2012 SG&A includes charges of $0.06 per diluted share for certain customer bankruptcies in the U.S., $0.03 per diluted share related to CFO transition costs and other certain charges of $0.05 per diluted share, noted above.  SG&A, as a percentage of sales, increased to 24.3% from 23.4% for the first nine months of 2011.  

The decrease in interest expense was due to lower average borrowings, partially offset by increases related to the accretion of certain acquisition-related liabilities.  

Other income decreased in the first nine months of 2012 primarily due to the non-cash gain recorded in the first nine months of 2011 related to the revaluation of the Company's previously held ownership interest in its Mexican affiliate to its fair value, as discussed above.  In addition, the Company experienced higher foreign exchange losses in the first nine months of 2012 and, also, received lower third party license fees in the first nine months of 2012, primarily as a result of the prior year purchase of the remaining ownership interest in the Company's Mexican affiliate, as discussed above. 

The Company's year-to-date 2012 and 2011 effective tax rates of 26.9% and 27.1%, respectively, reflect decreases in reserves for uncertain tax positions due to the expiration of applicable statutes of limitations for certain tax years of approximately $0.15 and $0.14 per diluted share, respectively.  The Company has experienced and expects to further experience volatility in its effective tax rates due to the varying timing of tax audits and the expiration of applicable statutes of limitations as they relate to uncertain tax positions, among other factors. 

The first nine months of 2012 earnings per diluted share of $2.52 reflect an approximate $0.11 per share dilutive effect as a result of the Company's equity offering in May of 2011. 

Balance Sheet and Cash Flow Items

In the first nine months of 2012, the Company's net cash provided by operating activities was $41.8 million, which surpasses any previous full year result.  Net operating cash flow of $19.8 million was generated in the third quarter of 2012, primarily led by the Company's third quarter net income and an improved working capital position.  The Company's consolidated leverage ratio remains strong at less than one times EBITDA.  In July 2012, the Company acquired NP Coil Dexter Industries, S.r.l. for net cash consideration of approximately $2.7 million.  

Non-GAAP Measures

Included in this public release is a non-GAAP financial measure of earnings per diluted share excluding a non-cash gain on the revaluation of a previously held ownership interest in a Mexican affiliate.  The Company believes this non-GAAP measure enhances a reader's understanding of the financial performance of the Company, is more indicative of the future performance of the Company and facilitates a better comparison among fiscal periods.  Non-GAAP results are presented for supplemental informational purposes only, and should not be considered a substitute for the financial information presented in accordance with GAAP.  The following is a reconciliation between the non-GAAP (unaudited) financial measure of earnings per diluted share excluding a non-cash gain on the revaluation of a previously held ownership interest in a Mexican affiliate to its most comparable GAAP measure (in thousands): 

Three Months Ended

September 30,

Nine Months Ended

September 30,

2012

2011

2012

2011

Earnings per diluted share

attributable to Quaker Chemical

Corporation

$        0.80

$        1.03

$         2.52

$        2.73

Non-cash gain on the revaluation

of a previously held ownership

interest in a Mexican affiliate per

diluted share

-

(0.22)

-

(0.22)

Earnings per diluted share

excluding a non-cash gain on the

revaluation of a previously held

ownership interest in a Mexican

affiliate

$        0.80

$        0.81

$         2.52

$        2.51

Forward-Looking Statements

This release contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements.  A major risk is that the Company's demand is largely derived from the demand for its customers' products, which subjects the Company to downturns in a customer's business and unanticipated customer production shutdowns.  Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence.  Other factors could also adversely affect us.  Therefore, we caution you not to place undue reliance on our forward-looking statements.  This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995. 

Conference Call

As previously announced, Quaker Chemical's investor conference call to discuss third quarter results is scheduled for October 31, 2012 at 8:30 a.m. (ET).  A live webcast of the conference call, together with supplemental information, can be accessed through the Company's Investor Relations Web site at http://www.quakerchem.com.  You can also access the conference call by dialing 877-270-2148. 

About Quaker

Quaker Chemical is a leading global provider of process fluids, chemical specialties, and technical expertise to a wide range of industries, including steel, aluminum, automotive, mining, aerospace, tube and pipe, cans, and others.  For nearly 100 years, Quaker has helped customers around the world achieve production efficiency, improve product quality, and lower costs through a combination of innovative technology, process knowledge, and customized services. Headquartered in Conshohocken, Pennsylvania USA, Quaker serves businesses worldwide with a network of dedicated and experienced professionals whose mission is to make a difference.

 

Quaker Chemical Corporation 

Condensed Consolidated Statement of Income

(Dollars in thousands, except per share data)

(Unaudited) 

Three Months Ended September 30, 

Nine Months Ended September 30, 

2012

2011

2012

2011

Net sales 

$           180,923

$           182,313

$           535,358

$           509,970

Cost of goods sold 

121,797

122,827

355,801

343,984

Gross profit

59,126

59,486

179,557

165,986

%

32.7%

32.6%

33.5%

32.5%

Selling, general and administrative expenses

43,263

41,982

130,009

119,441

Operating income 

15,863

17,504

49,548

46,545

%

8.8%

9.6%

9.3%

9.1%

Other income, net 

322

2,740

529

4,070

Interest expense

(1,034)

(1,166)

(3,359)

(3,584)

Interest income

149

262

409

805

Income before taxes and equity in net income of associated companies

15,300

19,340

47,127

47,836

Taxes on income before equity in net income of associated companies

4,373

5,640

12,692

12,961

10,927

13,700

34,435

34,875

Equity in net income of associated companies

257

105

612

715

Net income

11,184

13,805

35,047

35,590

Less: Net income attributable to noncontrolling interest

698

447

2,075

1,791

Net income attributable to Quaker Chemical Corporation

$              10,486

$              13,358

$              32,972

$              33,799

%

5.8%

7.3%

6.2%

6.6%

Per share data:

Net income attributable to Quaker Chemical Corporation Common Shareholders - basic

$                   0.80

$                   1.04

$                   2.54

$                   2.77

Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted

$                   0.80

$                   1.03

$                   2.52

$                   2.73

 

Quaker Chemical Corporation 

Condensed Consolidated Balance Sheet 

(Dollars in thousands, except par value and share amounts)

(Unaudited)

September 30,

December 31, 

2012

2011

ASSETS

Current assets 

Cash and cash equivalents 

$            30,172

$            16,909

Accounts receivable, net 

155,878

150,676

Inventories, net 

76,434

74,758

Prepaid expenses and other current assets 

18,576

17,206

Total current assets 

281,060

259,549

Property, plant and equipment, net

84,309

82,916

Goodwill 

59,461

58,152

Other intangible assets, net 

33,563

31,783

Investments in associated companies 

8,302

7,942

Deferred income taxes 

27,855

29,823

Other assets 

36,191

35,356

Total assets 

$         530,741

$         505,521

LIABILITIES AND EQUITY

Current liabilities 

Short-term borrowings and current portion of long-term debt 

$                  576

$                  636

Accounts and other payables 

74,277

68,125

Accrued compensation 

14,390

16,987

Other current liabilities 

22,812

20,901

Total current liabilities 

112,055

106,649

Long-term debt 

37,980

46,701

Deferred income taxes 

9,319

7,094

Other non-current liabilities 

86,162

89,351

Total liabilities 

245,516

249,795

Equity

Common stock, $1 par value; authorized 30,000,000 shares; issued 13,081,917 shares 

13,082

12,912

Capital in excess of par value 

93,845

89,725

Retained earnings 

199,388

175,932

Accumulated other comprehensive loss

(30,206)

(29,820)

Total Quaker shareholders' equity 

276,109

248,749

Noncontrolling interest

9,116

6,977

Total shareholders' equity

285,225

255,726

Total liabilities and equity 

$         530,741

$         505,521

 

Quaker Chemical Corporation 

Condensed Consolidated Statement of Cash Flows 

For the nine months ended September 30,

(Dollars in thousands)

(Unaudited)

2012

2011

Cash flows from operating activities 

Net income 

$    35,047

$    35,590

Adjustments to reconcile net income to net cash provided by operating activities: 

Depreciation 

9,001

8,527

Amortization 

2,283

1,596

Equity in undistributed earnings of associated companies, net of dividends 

(428)

(136)

Deferred compensation and other, net 

1,848

6,987

Stock-based compensation 

2,954

2,675

Non-cash gain from purchase of equity affiliate

-

(2,718)

Gain on disposal of property, plant and equipment

(75)

(61)

Insurance settlement realized 

(1,074)

(1,242)

Pension and other postretirement benefits

(1,823)

(4,099)

(Decrease) increase in cash from changes in current assets and current liabilities, net of

acquisitions: 

Accounts receivable

(1,381)

(29,390)

Inventories 

(875)

(16,334)

Prepaid expenses and other current assets 

(1,976)

(3,061)

Accounts payable and accrued liabilities 

(1,731)

6,196

Net cash provided by operating activities 

41,770

4,530

Cash flows from investing activities 

Investments in property, plant and equipment

(8,757)

(8,914)

Payments related to acquisitions, net of cash acquired

(2,635)

(10,981)

Proceeds from disposition of assets

193

221

Insurance settlement received and interest earned

53

61

Change in restricted cash, net 

1,021

1,181

Net cash used in investing activities 

(10,125)

(18,432)

Cash flows from financing activities 

Net decrease in short-term borrowings

-

(185)

Repayments of long-term debt 

(9,672)

(30,613)

Dividends paid 

(9,410)

(8,492)

Stock options exercised, other

(828)

629

Excess tax benefit related to stock option exercises

2,164

153

Proceeds from sale of common stock, net of related expenses

-

48,143

Distributions to noncontrolling shareholders

(30)

-

Net cash (used in) provided by financing activities 

(17,776)

9,635

Effect of exchange rate changes on cash 

(606)

(920)

Net increase (decrease) in cash and cash equivalents 

13,263

(5,187)

Cash and cash equivalents at the beginning of the period 

16,909

25,766

Cash and cash equivalents at the end of the period

$    30,172

$    20,579

 

SOURCE Quaker Chemical Corporation



RELATED LINKS

http://www.quakerchem.com